Extracellular Vesicle (Dec 2024)

An extracellular vesicle delivery platform based on the PTTG1IP protein

  • Carla Martin Perez,
  • Xiuming Liang,
  • Dhanu Gupta,
  • Emily R. Haughton,
  • Mariana Conceição,
  • Imre Mäger,
  • Samir EL Andaloussi,
  • Matthew J.A. Wood,
  • Thomas C. Roberts

Journal volume & issue
Vol. 4
p. 100054

Abstract

Read online

Extracellular vesicles (EVs) are promising therapeutic delivery vehicles, although their potential is limited by a lack of efficient engineering strategies to enhance loading and functional cargo delivery. Using an in-house bioinformatics analysis, we identified N-glycosylation as a putative EV-sorting feature. PTTG1IP (a small, N-glycosylated, single-spanning transmembrane protein) was found to be a suitable scaffold for EV loading of therapeutic cargoes, with loading dependent on its N-glycosylation at two arginine residues. Chimeric proteins consisting of PTTG1IP fused with various cargo proteins, and separated by self-cleaving sequences (to promote cargo release), were shown to enable highly efficient functional delivery of Cre protein to recipient cell cultures and mouse xenograft tumors, and delivery of Cas9-sgRNA complexes to recipient reporter cells. The favorable membrane topology of PTTG1IP enabled facile engineering of further variants with improved properties, highlighting its versatility and potential as a platform for EV-based therapeutics.

Keywords